Search Results - "Current opinion in pharmacology"
-
1
The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases
Published in Current opinion in pharmacology (01-12-2019)“…There is a recent growing evidence that abnormalities in the microbiota composition can have a major role in the development of obesity and diabetes and that…”
Get full text
Journal Article -
2
Flavonoids in hypertension: a brief review of the underlying mechanisms
Published in Current opinion in pharmacology (01-04-2019)“…Different pathways implicated in the effects of flavonoids on blood pressure regulation. [Display omitted] •Increased flavonoid consumption imparts…”
Get full text
Journal Article -
3
PD-1/PD-L1 inhibitors
Published in Current opinion in pharmacology (01-08-2015)“…Highlights • Remarkable and durable anti-tumor activity with several anti-PD-1/PD-L1 antibodies. • FDA approval for anti-PD-1 antibodies for advanced melanoma…”
Get full text
Journal Article -
4
Update on the antibiotic resistance crisis
Published in Current opinion in pharmacology (01-10-2014)“…Highlights • The antibiotic resistance crisis is jeopardizing feasibility of medical practices. • The antibiotic resistance crisis is more serious with…”
Get full text
Journal Article -
5
Focus on the essentials: tryptophan metabolism and the microbiome-gut-brain axis
Published in Current opinion in pharmacology (01-10-2019)“…[Display omitted] The gut-brain axis is a bidirectional communication system between the central nervous system and the gastrointestinal tract, in which…”
Get full text
Journal Article -
6
Cancer cell and macrophage cross-talk in the tumor microenvironment
Published in Current opinion in pharmacology (01-08-2017)“…•The tumor microenvironment contains innate immune cells, for example, macrophages.•Hypoxia imposes stress to tumor cells and their environment.•Tumor cell…”
Get full text
Journal Article -
7
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Published in Current opinion in pharmacology (01-06-2015)“…Highlights • Parathyroid hormone has dual anabolic and catabolic actions on the skeleton. • The OPG–RANKL–RANK pathway is the main mediator of the catabolic…”
Get full text
Journal Article -
8
Muscle as a paracrine and endocrine organ
Published in Current opinion in pharmacology (01-06-2017)“…Highlights • Skeletal muscle secretes myokines that exert autocrine paracrine and endocrine effects. • Paracrine factors modulate muscle angiogenesis,…”
Get full text
Journal Article -
9
Obesity and cancer: inflammation bridges the two
Published in Current opinion in pharmacology (01-08-2016)“…Highlights • Obesity is associated with chronic inflammation and chronic diseases. • Obesity is associated with increased risk and progression of several…”
Get full text
Journal Article -
10
Adipose tissue inflammation in obesity: a metabolic or immune response?
Published in Current opinion in pharmacology (01-12-2017)“…•Immunometabolism of the adipose tissue affects insulin resistance and obesity.•Type 2 immune response protects against diet-induced obesity.•Cytokines…”
Get full text
Journal Article -
11
Targeting CD73 to augment cancer immunotherapy
Published in Current opinion in pharmacology (01-08-2020)“…•CD73 is a multifunctional ectoenzyme affecting both tumor cells and immune cells.•CD73 has been hijacked by TME to promote tumor growth and…”
Get full text
Journal Article -
12
Immunosuppressive activities of adenosine in cancer
Published in Current opinion in pharmacology (01-08-2016)“…Highlights • Adenosine protects tissues against excessive inflammation and promotes tissue repair. • The adenosine pathway is hijacked to dampen anti-tumor…”
Get full text
Journal Article -
13
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases
Published in Current opinion in pharmacology (01-02-2022)“…Type 2 Diabetes Mellitus (T2D) is a chronic disease with a pandemic incidence whose pathogenesis has not yet been clarified. Raising evidence highlighted the…”
Get full text
Journal Article -
14
Targeting the renin–angiotensin system as novel therapeutic strategy for pulmonary diseases
Published in Current opinion in pharmacology (01-06-2018)“…•Renin angiotensin system (RAS) is believed to play a major role in regulating electrolyte balance and blood pressure.•Recent studies have implicated RAS…”
Get full text
Journal Article -
15
Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment
Published in Current opinion in pharmacology (01-10-2018)“…[Display omitted] •Management of tuberculosis is complicated by high levels of drug resistance in some regions of the world.•Increasingly, molecular…”
Get full text
Journal Article -
16
PI3K inhibitors in inflammation, autoimmunity and cancer
Published in Current opinion in pharmacology (01-08-2015)“…Highlights • Preclinical studies support us of PI3K inhibitors in autoimmunity and inflammation. • First in class PI3K inhibitor has been approved for…”
Get full text
Journal Article -
17
YAP/TAZ as therapeutic targets in cancer
Published in Current opinion in pharmacology (01-08-2016)“…Highlights • YAP/TAZ are activated in a broad number of solid tumors. • YAP/TAZ instrumental for tumor initiation, growth, metastasis and chemoresistance. •…”
Get full text
Journal Article -
18
Stem cell-based therapeutic strategies for cartilage defects and osteoarthritis
Published in Current opinion in pharmacology (01-06-2018)“…•ACI is the gold standard cell therapy for cartilage defect repair.•MSCs are promising substitutes for chondrocytes in ACI-like procedures.•Intra-articular MSC…”
Get full text
Journal Article -
19
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus
Published in Current opinion in pharmacology (01-12-2021)“…Diabetes mellitus is a complex disease. We are increasingly gaining a better understanding of its mechanisms at the molecular level. From these new insights,…”
Get full text
Journal Article -
20
Cachexia and sarcopenia: mechanisms and potential targets for intervention
Published in Current opinion in pharmacology (01-06-2015)“…Highlights • Cachexia and sarcopenia share common trends: altered protein synthesis and degradation. • Cachexia and sarcopenia are both driven by inflammation…”
Get full text
Journal Article